Instem PLC's (LON:INS) chief scientific officer and head of its informatics arm Dr Gordon Smith Baxter tells Proactive London the value of new orders for the division has grown by 58% to £840,000.
He says the firm's expansion into informatics is bringing them into contact with customers at an early stage in the drug development process.